Skip to content

Study on the Repair and Reconstruction of Alveolar Clefts Promoted by a Novel Controlled-Release Low-Dose BMP-2 Biomimetic Calcium Phosphate Material

Study on the Repair and Reconstruction of Alveolar Clefts Promoted by a Novel Controlled-Release Low-Dose BMP-2 Biomimetic Calcium Phosphate Material

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500114823
Enrollment
Unknown
Registered
2025-12-17
Start date
2026-01-01
Completion date
Unknown
Last updated
2026-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alveolar cleft

Interventions

Iliac group:Implantation of autologous iliac cancellous bone
BMP-2 group:Implantation of low-dose sustained-release BMP-2 material

Sponsors

Affiliated Stomatology Hospital of Wenzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
7 Years to 12 Years

Inclusion criteria

Inclusion criteria: 1. Patients aged 7–12 years with non-syndromic unilateral alveolar cleft (with or without cleft palate). 2. Cleft type: linear cleft; no large fistula present at the incisive foramen on the palatal side. 3. Patients without intellectual disability and able to cooperate with treatment. 4. No evidence of malnutrition. 5. Intact mucosa within the cleft, with retained deciduous teeth or ectopically erupted permanent teeth in the cleft area. 6. The subject (or legal guardian) voluntarily signs the informed consent form prior to any study-related procedures.

Exclusion criteria

Exclusion criteria: 1. Presence of a continuous bone bridge in the alveolar cleft region prior to surgery. 2. Presence of systemic diseases, including but not limited to bleeding disorders, skeletal disorders, or metabolic diseases. 3. History of alveolar cleft bone grafting. 4. Cleft width > 11 mm. 5. Presence of psychiatric disorders, severe psychological problems, or other conditions that impair oral hygiene maintenance or hinder cooperation. 6. Incomplete development of the permanent canine. 7. Patients requiring long-term high-dose corticosteroid therapy. 8. Presence of oral mucosal lesions (e.g., lichen planus, leukoplakia). 9. History of receiving full-dose radiotherapy or local radiotherapy to the head or neck. 10. Patients with immunodeficiency. 11. Poor compliance or inability to attend follow-up visits as scheduled. 12. Participation in another clinical trial involving drugs or medical devices within 30 days prior to Day 0 (surgery). 13. Use of anti-osteogenic or anticoagulant medications during the study period. 14. History of upper respiratory tract infection within the past two weeks. 15. Moderate rotation of the central incisor on the cleft side, leading to complete coverage of the cleft. 16. Vertical discrepancy between the two alveolar segments > one-half of the alveolar process height.

Design outcomes

Primary

MeasureTime frame
volume of the graft;Height of the graft;density of the graft;

Secondary

MeasureTime frame
Operation time;Postoperative pain level;Discharge time;

Countries

China

Contacts

Public ContactShufan Zhao

Affiliated Stomatology Hospital of Wenzhou Medical University

sf.zhao@wmu.edu.cn+86 185 6523 9566

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026